RECURRENT RESPIRATORY PAPILLOMATOSIS
Clinical trials for RECURRENT RESPIRATORY PAPILLOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT RESPIRATORY PAPILLOMATOSIS trials appear
Sign up with your email to follow new studies for RECURRENT RESPIRATORY PAPILLOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to reduce surgeries for rare HPV throat condition
Disease control Recruiting nowThis early-phase study tests two cancer drugs—lenvatinib (a daily pill) and pembrolizumab (an IV infusion)—in 20 adults with HPV-related recurrent respiratory papillomatosis (RRP) that has spread to the lungs. The goal is to see if the combination can shrink papillomas and reduce…
Matched conditions: RECURRENT RESPIRATORY PAPILLOMATOSIS
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental vaccine aims to tame rare throat tumor disease
Disease control Recruiting nowThis early-stage trial tests a custom-made vaccine for recurrent respiratory papillomatosis (RRP), a rare condition where non-cancerous growths keep coming back in the throat. The vaccine is made from each patient's own immune cells and designed to target the virus that causes RR…
Matched conditions: RECURRENT RESPIRATORY PAPILLOMATOSIS
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis study tests a gene therapy called Zopapogene imadenovec (Zopa) in 30 adults with recurrent respiratory papillomatosis (RRP), a condition causing non-cancerous throat tumors that often require repeated surgeries. One group will check how the virus used in the therapy leaves t…
Matched conditions: RECURRENT RESPIRATORY PAPILLOMATOSIS
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC